関連する実験動画

Updated: Jan 24, 2026

Enucleation of the Prostate for the Treatment of Benign Prostatic Hyperplasia Using a 980 nm Diode Laser

Enucleation of the Prostate for the Treatment of Benign Prostatic Hyperplasia Using a 980 nm Diode Laser

Published on: May 5, 2020

BPH患者におけるCOVID-19後の下部尿路症状の悪化

Ahmet Sanli^1,2, Guven Erbay^1,2, Ufuk Yavuz^1,2

¹Department of Urology, Karamanoglu Mehmetbey University Faculty of Medicine, Karaman, Turkiye.

Northern clinics of Istanbul

|January 23, 2026

要旨

Objective:

To evaluate the effects of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) on prostate volume, prostate-specific antigen (PSA) values, International Prostate Symptom Score (IPSS), maximum urinary flow rate (Q_max) andpostvoid residual urine volume (PVR) of patients with BPH.

Methods:

After retrospectively review the hospital database, the study included 104 patients aged 40-75 years, who were detected to have SARS-CoV-2 according to the reverse transcription-polymerase chain reaction (RT-PCR) test of combined oro-nasopharyngeal swab samples between March 2020 and December 2020 who were being followed for BPH and had undergone prostate volume, PSA, IPSS, Q_max and PVR measurements within one year prior to their COVID-19 diagnosis. The prostate volume, PSA, IPSS, Q_max and PVR parameters were compared before and after COVID-19.

Results:

The prostate volume, PSA, IPSS, Q_max and PVR values were compared pre-COVID-19 and post-COVID-19. No statistically significant changes were found in prostate volume and PSA levels (p>0.05), while a statistically significant difference was observed in IPSS, Q_max and PVR values, independent of the severity of the disease (p<0.001).

Conclusion:

COVID-19 appears to have a negative impact on IPSS, Q_max, and PVR in BPH patients in the short term.

キーワード:

良性前立腺肥大症 COVID-19 SARS-CoV-2 下部尿路症状尿路

さらに関連する動画

Surgical Treatment for Benign Prostatic Hyperplasia: Holmium Laser Enucleation of the Prostate HoLEP.

Surgical Treatment for Benign Prostatic Hyperplasia: Holmium Laser Enucleation of the Prostate HoLEP.

Published on: March 6, 2018

Renal Capsule Xenografting and Subcutaneous Pellet Implantation for the Evaluation of Prostate Carcinogenesis and Benign Prostatic Hyperplasia

Renal Capsule Xenografting and Subcutaneous Pellet Implantation for the Evaluation of Prostate Carcinogenesis and Benign Prostatic Hyperplasia

Published on: August 28, 2013

関連する概念動画

Urinary Tract Calculi I: Introduction

Urinary Tract Calculi I: Introduction

Renal calculi, or kidney stones, are solid deposits of minerals and salts formed inside the kidneys. In medical terminology, "calculus" refers to the stone itself, while "lithiasis" describes the process of stone formation. Depending on their location within the urinary system, these stones may be classified as either urolithiasis, when situated within the urinary tract, or nephrolithiasis, when located within the kidneys. Each term signifies the specific impact of the stone.Predisposition...

Urinary Tract Infection I: Introduction

Urinary Tract Infection I: Introduction

Urinary tract infections (UTIs) impact various parts of the urinary system, including the kidneys, ureters, bladder, and urethra. These infections are generally bacterial, with Escherichia coli being the most common causative agent, often originating from the gastrointestinal tract. However, other bacteria, such as Staphylococcus saprophyticus, Klebsiella pneumoniae, and Proteus mirabilis, are also known to cause UTIs. The type, location, and underlying complexity of the UTI guide both...

Urinary Tract Infection II: Pathophysiology

Urinary Tract Infection II: Pathophysiology

The pathophysiology of urinary tract infections (UTIs) encompasses several progressive stages, beginning with bacterial colonization and culminating in potential systemic complications if untreated. UTIs are primarily initiated by bacteria, such as Escherichia coli, which often originate from the gastrointestinal tract and migrate to the urinary system through the periurethral area. This migration can occur via several routes, including improper hygiene practices, sexual activity, or...

Urinary Tract Calculi V: Nursing Management

Urinary Tract Calculi V: Nursing Management

AssessmentSubjective Data: Obtain a detailed health history, including any recent or chronic urinary tract infections, periods of immobilization, previous episodes of renal calculi, and medical conditions such as gout, benign prostatic hyperplasia, or hyperparathyroidism. Review the medication history for drugs that may influence stone formation, including allopurinol, analgesics, loop diuretics, or thiazide diuretics. Document the use of long-term indwelling catheters and any past surgical...

Urinary Tract Calculi VI: Surgical Management

Urinary Tract Calculi VI: Surgical Management

Procedures for Kidney StonesMedical intervention is necessary when kidney stones or renal calculi are too large to pass spontaneously (typically greater than 5 millimeters) when stones are accompanied by symptomatic infection (such as fever or pyelonephritis), when they impair kidney function, or when they cause persistent symptoms like severe pain, nausea, or urinary retention. Additionally, patients with only one kidney or those who cannot be treated with medical management also require...

Urinary Tract Infection IV: Nursing Management

Urinary Tract Infection IV: Nursing Management

In managing urinary tract infections (UTIs) in nursing, a comprehensive assessment is essential. Begin by gathering subjective data, such as the patient’s complaints of dysuria (painful urination), urinary frequency, urgency, suprapubic pain, and any lower abdominal discomfort. This information can be complemented by questions regarding previous UTIs, sexual activity, and personal hygiene practices, which can provide insight into risk factors. Objective assessment should focus on signs...